Transthyretin Amyloidosis (ATTR)

European ATTR Amyloidosis Meeting (EU-ATTR) 2025

Congress Details

September 25-26, 2025

Baveno, VB, Italy

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Congress Materials

ATTR-CM

Presentation Type

Presentation

Location

Baveno, VB, Italy

Title

Efficacy and Safety of Vutrisiran in ATTR-CM Across the Spectrum of Age

ATTR-Discrete

Presentation Type

Poster

Location

Baveno, VB, Italy

Title

Clinician preferences for transthyretin amyloidosis treatment: Results from a discrete-choice experiment

ATTR-Holistic

Presentation Type

Poster

Location

Baveno, VB, Italy

Title

Holistic clinical management of ATTR amyloidosis with cardiomyopathy

Login and Sign up

Left Image

RNAiScience Data Hall is for healthcare professionals. By creating an account, you will have access to:

- All RNAi on-demand educational content
- Personalization experience with ability to bookmark content for future reference

First Name *

Last Name *

Enter your Institution Email *

Password *

Country *

Select Speciality *

Select Profession *

* Required Fields

By signing up you agree to Alnylam Terms of Conditions and Privacy Policy.